International Scholarly Research Notices / 2012 / Article / Fig 4

Research Article

Application of a Reliable LC-MS/MS Method for Determination of Rizatriptan in Healthy Subject Samples: Demonstration of Assay Reproducibility by Incurred Sample Reanalysis

Figure 4

Mean plasma concentration-time profile of rizatriptan after oral administration of test (10 mg rizatriptan orally disintegrating tablets of a generic company) and a reference (MAXALT-MLT, 10 mg rizatriptan benzoate orally disintegrating tablets from Merck & Co. Inc, Whitehouse station, NJ 08889, USA) formulation to 40 and 32 healthy subjects under fasting and fed conditions, respectively.
(a)   Fasting
(b) Fed

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.